down arrow

Makers Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE987A01010
  • NSEID:
  • BSEID: 506919
INR
134.00
0.00 (0.00%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 871

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Makers Laboratories Ltd stock-summary
stock-summary
Makers Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Makers Laboratores Limited (MLL) was incorporated in the State of Maharashtra, which commenced business from 21st July, 1984. The Company was promoted by Satish Kumar Gupta and Naval Tated. The Company is presently in manufacture of pharmaceutical formulations and drug intermediates. Makers Drugs & Food Products Ltd. (MDFP) was amalgamated with the Company with effect from 1st April 1993.
Company Coordinates stock-summary
Company Details
54 D Kandivli Industrial Estat, Charkop Kandivli (West) Mumbai Maharashtra : 400067
stock-summary
Tel: 91-22-2868 8544
stock-summary
investors@makerslabs.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 5.90 Cr
Number of Shares
59 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
30-Mar-2022
59
5.90
983396
10
Right Issues
22-Apr-2011
49.17
4.92
571440
10
Amalgamation
22-Apr-2011
49.17
4.92
571440
10
Amalgamation
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Kaygee Investments Private Limited (17.38%)

Highest Public shareholder

Tanvi Jignesh Mehta (2.12%)

Individual Investors Holdings

30.67%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
R K P Verma
Chairman & Independent Directo
2.0 lacs
Dipti Shah
Independent Non Exe. Director
1.8 lacs
Vishal Jain
Independent Non Exe. Director
2.3 lacs
Prashant Godha
Non-Exec & Non-Independent Dir
90.0 k
Saahil U Parikh
Non Independent Executive Dire
55.47 lacs
Nilesh Jain
Non Independent Executive Dire
33.66 lacs
Surbhi Sharma
Company Sec. & Compli. Officer
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Other Purchases
0.132
0%
 
100
Other Purchases
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Formulations
38.82
83.26%
Services
7.75
16.62%
Sundry Creditors Balances
0.04
0.09%
 
83.26
Formulations
16.74
Formulations
16.62
Services
83.38
Services
0.09
Sundry Creditors Balances
99.91
Sundry Creditors Balances
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
28 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 79 Cr (Micro Cap)

stock-summary
P/E

11.00

stock-summary
Industry P/E

27

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.19

stock-summary
Return on Equity

8.81%

stock-summary
Price to Book

1.20